Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$125B
1-Year Return
23.89%
This Quarter Return
+3.61%
1 Year Return
+23.89%
3 Year Return
+93.04%
5 Year Return
+163.06%
10 Year Return
+400.91%
AUM
$103B
AUM Growth
+$9.68B
(+10%)
Cap. Flow
+$7.53B
Cap. Flow
% of AUM
7.29%
Top 10 Holdings %
Top 10 Hldgs %
32.78%
Holding
1,619
New
26
Increased
800
Reduced
164
Closed
25
Top Buys
| 1 |
Apple
AAPL
|
+$579M |
| 2 |
NVIDIA
NVDA
|
+$486M |
| 3 |
Microsoft
MSFT
|
+$433M |
| 4 |
Amazon
AMZN
|
+$280M |
| 5 |
Procter & Gamble
PG
|
+$269M |
Top Sells
| 1 |
Booking.com
BKNG
|
+$140M |
| 2 |
Texas Instruments
TXN
|
+$82M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$50.1M |
| 4 |
Amgen
AMGN
|
+$24.5M |
| 5 |
Tradeweb Markets
TW
|
+$23.3M |
Sector Composition
| 1 | Technology | 31.77% |
| 2 | Financials | 14.48% |
| 3 | Healthcare | 11.89% |
| 4 | Consumer Discretionary | 10.63% |
| 5 | Communication Services | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Roivant Sciences
ROIV
$9.4B
| $183K | ﹤0.01% |
15,676
-1,574
| -9% | -$18.4K |
|
1002
CVRx
CVRX
$205M
| $183K | ﹤0.01% |
13,434
-10,503
| -44% | -$143K |
|
1003
Sanofi
SNY
$115B
| $182K | ﹤0.01% |
3,779
-88
| -2% | -$4.24K |
|
|
CDMO
1004
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $179K | ﹤0.01% |
+14,544
| New | +$179K |
|
1005
IDEAYA Biosciences
IDYA
$2.17B
| $178K | ﹤0.01% |
6,856
-30,870
| -82% | -$803K |
|
1006
BILL Holdings
BILL
$5.38B
| $177K | ﹤0.01% |
2,008
-487
| -20% | -$43K |
|
1007
RingCentral
RNG
$2.77B
| $176K | ﹤0.01% |
4,983
+468
| +10% | +$16.6K |
|
1008
Box
BOX
$4.74B
| $175K | ﹤0.01% |
5,570
-330
| -6% | -$10.4K |
|
1009
Weave Communications
WEAV
$584M
| $174K | ﹤0.01% |
10,903
+597
| +6% | +$9.52K |
|
1010
Avidity Biosciences
RNA
$5.97B
| $171K | ﹤0.01% |
5,621
-3,292
| -37% | -$100K |
|
1011
Payoneer
PAYO
$2.33B
| $170K | ﹤0.01% |
16,208
-4,913
| -23% | -$51.5K |
|
1012
Toronto Dominion Bank
TD
$130B
| $169K | ﹤0.01% |
3,139
+957
| +44% | +$51.5K |
|
1013
Agilysys
AGYS
$3.03B
| $168K | ﹤0.01% |
1,264
-46
| -4% | -$6.13K |
|
1014
i3 Verticals
IIIV
$720M
| $168K | ﹤0.01% |
7,130
+1,488
| +26% | +$35K |
|
1015
Novartis
NVS
$245B
| $168K | ﹤0.01% |
1,717
-167
| -9% | -$16.3K |
|
1016
ING
ING
$73B
| $167K | ﹤0.01% |
10,647
+3,728
| +54% | +$58.3K |
|
1017
4D Molecular Therapeutics
FDMT
$324M
| $166K | ﹤0.01% |
28,041
+17,576
| +168% | +$104K |
|
1018
Green Dot
GDOT
$757M
| $164K | ﹤0.01% |
16,513
+3,339
| +25% | +$33.2K |
|
|
FINV
1019
FinVolution Group
FINV
$1.94B
| $164K | ﹤0.01% |
23,722
+4,146
| +21% | +$28.6K |
|
1020
Immatics
IMTX
$706M
| $163K | ﹤0.01% |
22,701
+4,477
| +25% | +$32.1K |
|
1021
CompoSecure
CMPO
$1.97B
| $161K | ﹤0.01% |
12,282
+3,067
| +33% | +$40.3K |
|
1022
Sangamo Therapeutics
SGMO
$160M
| $161K | ﹤0.01% |
+124,037
| New | +$161K |
|
1023
Deluxe
DLX
$858M
| $161K | ﹤0.01% |
7,084
+2,239
| +46% | +$50.8K |
|
1024
Scotiabank
BNS
$79.4B
| $161K | ﹤0.01% |
3,007
+464
| +18% | +$24.8K |
|
1025
Lightspeed Commerce
LSPD
$1.58B
| $158K | ﹤0.01% |
10,073
+2,168
| +27% | +$34.1K |
|